{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:13:31Z","timestamp":1789535611950,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      To observe the medium- and long-term clinical efficacy and safety of radioactive\n                      <jats:sup>125<\/jats:sup>\n                      I seed implantation for refractory malignant tumours based on CT-guided 3D template-assisted technique.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Twenty-five patients with refractory malignant tumours who underwent radioactive\n                      <jats:sup>125<\/jats:sup>\n                      I seed implantation based on CT-guided 3D template-assisted technique were selected. The post-operative adverse reactions were recorded. The number of puncture needles and particles used in the operation, dosimetric parameters, post-operative physical strength scores, and tumour response were statistically analysed. The overall survival time and survival rate were calculated, and the effect and prognosis were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:sup>125<\/jats:sup>\n                      I seed implantation was successful in all patients without serious complications. The average number of implanted puncture needles was 17 (19.12\u2009\u00b1\u200913.00), and the median number of particles was 52 (55.12\u2009\u00b1\u200932.97). D\n                      <jats:sub>90<\/jats:sub>\n                      in the post-operative clinical target volume (CTV) (93.24\u2009\u00b1\u200915.70\u2009Gy) was slightly lower than that in the pre-operative CTV (93.92\u2009\u00b1\u200917.60\u2009Gy;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). The D\n                      <jats:sub>90<\/jats:sub>\n                      in the post-operative planning target volume (PTV) (142.16\u2009\u00b1\u200922.25\u2009Gy) was lower than the pre-operative PTV (145.32\u2009\u00b1\u200923.48\u2009Gy;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). The tumour responses at 6\u2009months post-operatively: complete remission (CR), 20% (5\/25); partial remission (PR), 48% (12\/25); stable disease (SD), 24% (6\/25); progressive disease (PD), 8% (2\/25); CR\u2009+\u2009PR, 68% (17\/25); and local control rate, 92% (23\/25). The 6-, 12-, and 24-month survival rates were 100, 88, and 52%, respectively. The post-operative physical strength score (Karnofsky performance score, KPS) exhibited a gradual trend towards recovery, which rose to the highest value 12\u2009months after implantation and then decreased slightly, but the average score was still &gt;\u200990 points. There was one intra-operative pneumothorax, and two patients with superficial malignant tumours developed skin ulcerations. Multivariate analysis of prognosis showed that tumour sites and types were independent risk factors affecting survival. The number of needles and particles and template types were not the factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      3D template combined with CT-guided radioactive\n                      <jats:sup>125<\/jats:sup>\n                      I seed implantation can improve the rational distribution of radiation dose in the tumour target area because accurate radioactive\n                      <jats:sup>125<\/jats:sup>\n                      I particle implantation was achieved. This technique has fewer complications and can further extend the overall survival and improve the quality of life.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Registration number:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/index.aspx\">ChiCTR2000034566<\/jats:ext-link>\n                      2020\/7\/10 0:00:00\n                    <\/jats:p>\n                    <jats:p>Retrospectively registered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07223-3","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T08:06:34Z","timestamp":1596441994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety"],"prefix":"10.1186","volume":"20","author":[{"given":"Guang Sheng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"7223_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000467114","volume":"31","author":"SB Nachbichler","year":"2018","unstructured":"Nachbichler SB, Kreth FW. Brachytherapy of intracranial Gliomas. Prog Neurol Surg. 2018;31:72\u201386.","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"7223_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7785\/tcrt.2012.500402","volume":"14","author":"P Jiang","year":"2015","unstructured":"Jiang P, Liu C, Wang J, et al. Computed tomography (CT)-guided interstitial permanent implantation of (125) I seeds for refractory chest wall metastasis or recurrence. Technol Cancer Res Treat. 2015;14(1):11\u20138.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"7223_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/jcrt.JCRT_888_17","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang J, Chai S, Zheng G, et al. Chinese expert consensus on radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer. J Cancer Res Ther. 2018;14(1):12\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"7223_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/jcrt.JCRT_619_17","volume":"14","author":"Y Liang","year":"2018","unstructured":"Liang Y, Wang Z, Zhang H, et al. Three-dimensional-printed individual template-guided 125I seed implantation for the cervical lymph node metastasis: a dosimetric and security study. J Cancer Res Ther. 2018;14(1):30\u20135.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"7223_CR5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7223_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","volume":"30","author":"W Chen","year":"2018","unstructured":"Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1\u201312.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"7223_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4103\/jcrt.JCRT_6_19","volume":"15","author":"ZY Lin","year":"2019","unstructured":"Lin ZY, Yang JY, Chen J, et al. Evaluating the effectiveness of computed tomography-guided 125I seed interstitial implantation in patients with secondary adrenal carcinoma. J Cancer Res Ther. 2019;15(4):813\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"7223_CR8","first-page":"3737","volume":"11","author":"F Dai","year":"2019","unstructured":"Dai F, Wang J, An H, et al. Therapy of 125I particles implantation inhibited the local growth of advanced non-small cell lung cancer:a retrospective clinical study. Am J Transl Res. 2019;11(6):3737\u201349.","journal-title":"Am J Transl Res"},{"issue":"2","key":"7223_CR9","first-page":"642","volume":"24","author":"Q Liu","year":"2019","unstructured":"Liu Q, Dai X, Zhou X, et al. Comparison of TACE combined with and without iodine-125 seeds implantation therapy for advanced stage hepatocellular carcinoma:a systematic review and meta-analysis. J BUON. 2019;24(2):642\u20139.","journal-title":"J BUON"},{"issue":"7","key":"7223_CR10","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00432-019-02943-x","volume":"145","author":"Z Xiang","year":"2019","unstructured":"Xiang Z, Bai M, Li G, et al. Safety and efficacy of 125I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation. J Cancer Res Clin Oncol. 2019;145(7):1907\u201316.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"7223_CR11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00330-017-5036-0","volume":"28","author":"Z Mo","year":"2018","unstructured":"Mo Z, Zhang T, Zhang Y, et al. Feasibility and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure. Eur Radiol. 2018;28(3):1194\u2013203.","journal-title":"Eur Radiol"},{"issue":"1","key":"7223_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12957-016-1050-y","volume":"14","author":"C Wang","year":"2016","unstructured":"Wang C, Chen Z, Sun W, et al. Palliative treatment of pelvic bone tumors using radioiodine (125I ) brachytherapy. World J Surg Oncol. 2016;14(1):294.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"7223_CR13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5114\/jcb.2019.84503","volume":"11","author":"Z Ji","year":"2019","unstructured":"Ji Z, Sun HT, Jiang YL, et al. Comparative study for CT-guided 125I seed implantation assisted by 3D printing coplanar and non-coplanar template in peripheral lung cancer. J Contemp Brachyther. 2019;11(2):169\u201373.","journal-title":"J Contemp Brachyther"},{"issue":"46","key":"7223_CR14","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.3748\/wjg.v24.i46.5280","volume":"24","author":"W Huang","year":"2018","unstructured":"Huang W, Lu J, Chen KM, et al. Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. World J Gastroenterol. 2018;24(46):5280\u20137.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"7223_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4103\/jcrt.JCRT_347_18","volume":"15","author":"H Zhang","year":"2019","unstructured":"Zhang H, Dev D, Yu H, et al. Feasibility of three-dimensional-printed template-guided 125I seed brachytherapy and dosimetric evaluation in patients with malignant tumor. J Cancer Res Ther. 2019;15(4):793\u2013800.","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"7223_CR16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O'Donnell","year":"2019","unstructured":"O'Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16(3):151\u201367.","journal-title":"Nat Rev Clin Oncol"},{"issue":"18","key":"7223_CR17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(17)30516-8","volume":"18","author":"S Turajlic","year":"2017","unstructured":"Turajlic S, Litchfield K, Xu H, et al. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. Lancet Oncol. 2017;18(18):1009\u201321.","journal-title":"Lancet Oncol"},{"issue":"2","key":"7223_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00268-018-4816-2","volume":"43","author":"H Omori","year":"2019","unstructured":"Omori H, Tanizawa Y, Makuuchi R, et al. Role of palliative resection in patients with incurable advanced gastric cancer who are unfit for chemotherapy. World J Surg. 2019;43(2):571\u20139.","journal-title":"World J Surg"},{"issue":"4","key":"7223_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10147-018-1363-7","volume":"24","author":"S Hiramoto","year":"2019","unstructured":"Hiramoto S, Tamaki T, Nagashima K, et al. Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer. Int J Clin Oncol. 2019;24(4):454\u20139.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"7223_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/jcb.2019.82768","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Zhang L, Xie Q, et al. How many times 125I seed implantation brachytherapy can be repeated for pulmonary metastases: clinical efficacy and complications. J Contemp Brachytherapy. 2019;11(1):35\u201340.","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"7223_CR21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/jcrt.JCRT_888_17","volume":"14","author":"J Wang","year":"2018","unstructured":"Wang J, Chai S, Zheng G, et al. Expert consensus statement on computed tomography-guided 125I radioactive seeds permanent interstitial brachytherapy. J Cancer Res Ther. 2018;14(1):12\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"11","key":"7223_CR22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/14737159.2017.1381561","volume":"17","author":"F Salvianti","year":"2017","unstructured":"Salvianti F, Pinzani P. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients. Expert Rev Mol Diagn. 2017;17(11):975\u201381.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07223-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T19:16:31Z","timestamp":1627931791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07223-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7223"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07223-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17493\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17493\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17493\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17493\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Affiliated Zhongshan Hospital of Dalian University. All the patients have signed the informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"718"}}